Showing results (401-410 of 9,939) with videos related to

Sort By:
Pageof 994
Orbit (Amsterdam, Netherlands)|June 24, 2008
Hybrid neurofibroma-schwannoma of the orbitKenneth E Youens, Julie Woodward, Dana Wallace, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1993
Stability of GR63178A, a novel pentacyclic pyrroloquinone anticancer compound, in aqueous solutions and biological fluidsR C French, J Cummings, M Nicolson, et al.
The Journal of Prevention of Alzheimer'S Disease|July 16, 2022
Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer's DiseaseS Cohen, J Cummings, S Knox, et al.
Biopharmaceutics & Drug Disposition|January 1, 1985
Adriamycin-loaded albumin microspheres: preparation, in vivo distribution and release in the ratN Willmott, J Cummings, J F Stuart, et al.
The Journal of Prevention of Alzheimer'S Disease|April 5, 2018
Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer's Disease Task ForceJ Cummings, N Fox, B Vellas, et al.
Clinics in Chest Medicine|July 30, 2023
Occupational Contributions to Respiratory Health DisparitiesSheiphali A Gandhi, Amy Heinzerling, Jennifer Flattery, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|October 12, 1999
Development of a gradient elution high-performance liquid chromatography assay with ultraviolet detection for the determination in plasma of the anticancer peptide [Arg6, D-Trp7,9, mePhe8]-substance P (6-11) (antagonist G), its major metabolites and a C-terminal pyrene-labelled conjugateJ Cummings, A J MacLellan, M Mark, et al.
Anti-Cancer Drug Design|October 1, 1995
Identification of anthracenyl-dipeptide conjugates as novel topoisomerase I and II inhibitors and their evaluation as potential anticancer drugsI Meikle, J Cummings, J S Macpherson, et al.
Journal of Chromatography. B, Biomedical Applications|October 11, 1996
Determination of the novel topoisomerase I inhibitor NU/ICRF 505 and its major metabolite in plasma, tissue and tumour by high-performance liquid chromatographyJ Cummings, I Meikle, J S Macpherson, et al.
Biochemical Pharmacology|October 11, 1996
Development of anthracenyl-amino acid conjugates as topoisomerase I and II inhibitors that circumvent drug resistanceJ Cummings, J S Macpherson, I Meikle, et al.
Pageof 994